این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
International Journal of Hematology-Oncology and Stem Cell Research، جلد ۲، شماره ۲، صفحات ۱-۴
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی A Survey of 121 patients with Idiopathic Thrombocytopenic Purpura
چکیده انگلیسی مقاله Introduction: Idiopathic Thrombocytopenic Purpura is one of the most common causes of thrombocy-topenia with varius clinical courses and different responses to its treatment modalities. Therefore, we decided to evaluate the clinical course of this disease in our patients. Methods: In this case series study, from March 1998 to March 2004, we evaluated 121 patients. As a first line of treatment, all of those patients received prednisolone (1mg/kg/day) for 6 weeks. Those who didn't respond or were refractory to prednisolone were candidates for splenectomy, and those who re‌fused these modalities or didn't respond to them were treated with Azathioprine. Results: 99 patients (81.8%) were female and 22 (18.2%) were male, aged 11-73 years (mean; 28.6). Two patients had immune hemolytic anemia in addition to thrombocytopenia, 4 had systemic lupus erythematosus, and one was HIV positive. %44.6 of patients fully responded to prednisolone, 42 pa‌tients (%34.7) underwent splenectomy and %83.3 of them responsed to it.31 splenectomies were per‌formed in the first three months after diagnosis and 27 (87.1%) of them showed complete response, but 8 (72.7%) of the patients splenectomized after 3 months, had complete response. 14 patients were treated with Azathoprine, 2 of which (14.3%) platelet count normalized. Conclusion: ITP is more common in females than males. Prednisolone is preferred as a non-invasive treatment with suitable response in comparison to other modalition responses to splenectomy, indicat‌ing that this modality of treatment is useful and effective, especially when performaed in the first 3 months of the diseases.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله a شهریاریاحمدی | a shahriariahmadi
department of hematology–oncology, taleghani hospital, kermanshah university of medical science, iran


m طهماسیان | m tahmasian
department of hematology–oncology, taleghani hospital, kermanshah university of medical science, iran
نشانی اینترنتی http://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/184
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Articles
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات